洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2400082766】Implementation of an integrated Self-Care Health Service Ecosystem

基本信息
登记号

ChiCTR2400082766

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-04-07

临床申请受理号

/

靶点

/

适应症

None

试验通俗题目

Implementation of an integrated Self-Care Health Service Ecosystem

试验专业题目

Development and implementation of an integrated Self-Care Health Service Ecosystem

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

This seed project will serve as the first phase of the development and implementation of the self-care health service ecosystem. During the first phase, we will mainly focus on the conceptualization and planning, and creation of prototype of SHE. Thus, this project aims to: 1) To identify the core features of the app and prioritize them to create the Minimum Viable Product; 2) To create wireframes and prototype to visualize the app’s layout, user flow, and interactions (prototype creation); 3) To understand users’ experience on the use of HPV self-sampling and Dried Blood Spot (DBS) in general population (experience test); 4) To validate the risk algorithms for disease prevention and health problem alert; and 5) To explore the health information that the users are in need and can be used to train the chatbot (needs exploration).

试验分类
请登录查看
试验类型

横断面

试验分期

其它

随机化

N/A

盲法

None

试验项目经费来源

Innovation and Technology Fund

试验范围

/

目标入组人数

192

实际入组人数

/

第一例入组时间

2023-12-01

试验终止时间

2025-12-01

是否属于一致性

/

入选标准

1) HK resident; 2) Aged 18 or above; and 3) Able to read, understand and speaking Cantonese or English.;

排除标准

1) Current pregnancy at the time of recruitment; 2) Had total hysterectomy; 3) Have been diagnosed with an immunocompromised condition (e.g. Systemic Lupus Erythematosus, or illness with steroid-dependent); or 4) Have been diagnosed with any gynecologic cancers (e.g. cervical, ovarian, vaginal, uterine, vulvar, or breast cancer).;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Chinese University of Hong Kong的其他临床试验

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用